Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Kiniksa Pharmaceuticals International (KNSA) Return on Assets (2018 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Return on Assets readings, the most recent being 0.0% for Q1 2026.

  • On a quarterly basis, Return on Assets changed 0.0% to 0.0% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Assets hit 0.0% in Q1 2026 for Kiniksa Pharmaceuticals International, up from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2022 to a low of 0.01% in Q1 2022.
  • Median Return on Assets over the past 5 years was 0.0% (2025), compared with a mean of 0.0%.
  • Biggest five-year swings in Return on Assets: rose 1bps in 2022 and later decreased -1bps in 2023.
  • Kiniksa Pharmaceuticals International's Return on Assets stood at 0.0% in 2022, then tumbled by -197bps to 0.0% in 2023, then soared by 66bps to 0.0% in 2024, then surged by 228bps to 0.0% in 2025, then increased by 15bps to 0.0% in 2026.
  • The last three reported values for Return on Assets were 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025) per Business Quant data.